C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
12/2006
12/05/2006	US7144965 Halogenated styrene compounds and very low-loss polymers made therefrom
12/05/2006	US7144911 Anti-inflammatory medicaments
11/2006
11/30/2006	WO2006017409A3 1,3-disubstituted heteroaryl nmda/nr2b antagonists
11/29/2006	EP1725524A1 Substituted heteroaryl- and phenylsulfamoyl compounds
11/29/2006	EP1725231A1 Triazole, oxadiazole and thiadiazole derivatives as ppar modulators for the treatment of diabetes
11/29/2006	EP1725102A1 Hiv integrase inhibitors
11/29/2006	EP1005462B1 Method for the production of 3-isopropyl-ih-2, 1,3-benzothiadiazine-4 (3h)-one-2,2-dioxide
11/29/2006	CN1871219A Hexylcarboxanilide
11/28/2006	US7141672 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/23/2006	WO2006081034A3 Anti-inflammatory medicaments
11/23/2006	US20060264435 Novel compounds
11/22/2006	EP1723128A1 Heteroaryl-ureas and their use as glucokinase activators
11/22/2006	EP1322674B1 Control agents for living-type free radical polymerization, methods of polymerizing, emulsions and polymers with same
11/22/2006	EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006	CN1867560A 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
11/22/2006	CN1865252A 4,5-di-substituted-phenyl-1,2,3-thiadia-zole derivative, and its preparation method and uses
11/21/2006	US7138533 acetylcholinesterase inhibitory action and an alpha 1 antagonistic action
11/21/2006	US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006	CA2272285C Amide derivatives and medicinal compositions thereof
11/16/2006	WO2006122319A2 Histone deacetylase inhibitors
11/16/2006	WO2006120133A2 Process for coloring keratin fibers comprising metal complexes
11/16/2006	US20060258723 Substituted Heteroaryl- and Phenylsulfamoyl Compounds
11/16/2006	US20060258719 Modulators of indoleamine 2,3-dioxygenase and methods of using the same
11/16/2006	DE102005022642A1 2,6-Naphthylreste enthaltende Verbindungen 2,6-naphthyl-containing compounds
11/15/2006	EP1720846A1 Use of thiadiazole urea derivatives
11/15/2006	EP0956329B1 Dithiocarbamate derivatives and lubricants containing same
11/15/2006	CN1864434A Wireless microphone communication system
11/15/2006	CN1863785A Compositions useful as inhibitors of voltage-gated sodium channels
11/15/2006	CN1862871A Electrolytic solution and battery
11/15/2006	CN1862852A Application of organic sulfide in positive electrode material of secondary Mg battery
11/15/2006	CN1861585A Process of preparing 3-substituted 5-azo substituting group substituted-[1,3,4]-thia-dizole-2-thione
11/14/2006	CA2128955C Tricyclic benzazepine vasopressin antagonists
11/08/2006	EP1719768A1 Novel benzothiazepine and benzothiepine compounds
11/08/2006	EP1718628A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
11/08/2006	EP1718626A1 Sulfonylpyrrolodine modulators of androgen receptor fuction and method
11/08/2006	EP1718625A1 Compounds
11/07/2006	US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006	US7132547 Preventives/remedies for urinary disturbance
11/07/2006	US7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia
11/02/2006	WO2006114260A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/02/2006	WO2006084854A3 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
11/02/2006	US20060247289 Certain chemical entities, compositions, and methods
11/02/2006	US20060247178 Mitotic kinesin inhibitors and methods of use thereof
11/02/2006	EP1716127A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/02/2006	EP1716122A1 Modulators of atp-binding cassette transporters
11/02/2006	EP1446394B1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
11/02/2006	CA2605262A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/01/2006	CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/2006
10/26/2006	WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006	US20060241301 Urea derivatives and their use as tyrosinkinase inhibitors
10/25/2006	EP1713799A2 Compounds and compositions as lxr modulators
10/25/2006	EP1713460A2 Fk228 analogs and their use as hdac-inhibitors
10/25/2006	EP1509231A4 Peritoneal dialysis solution with taurolidine
10/25/2006	CN1850812A Imidazole derivative, and its preparing method and pharmaceutical use for anti tubercle bacillus
10/25/2006	CN1281592C Process for preparing 1,2,4-benzothiadiaxine-1,1-dioxide compound
10/24/2006	US7125988 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent; excellent in color reproducibility and image storability
10/19/2006	WO2005023182A3 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
10/18/2006	CN1280277C Diamide invertebrate pest control agents contg. non-aromatic heterocyclic ring
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122565 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
10/17/2006	US7122541 LIVER CANCER; ADMINISTERING TAUROLIDINE, direct contact a liver tissue by perfusion in situ, to increase caspase activity in a cell
10/17/2006	CA2226669C Herbicidal sulphonylamino(thio)carbonyl compounds
10/12/2006	WO2006106960A1 Process for producing disulfonyl fluoride compound
10/12/2006	DE112004002193T5 Halogenierte Bisdiarylamino-polycyclische aromatische Verbindungen und Polymere davon Halogenated Bisdiarylamino polycyclic aromatic compounds and polymers thereof
10/11/2006	EP1710238A1 Benzophenones as inhibitors of reverse transcriptase
10/11/2006	EP1708713A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system
10/11/2006	CN1846456A Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone
10/11/2006	CN1845924A Arylamine-substituted quinazolinone compounds
10/10/2006	US7119099 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives
10/05/2006	WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors
10/05/2006	WO2006102760A1 Inhibitors of histone deacetylase
10/05/2006	US20060223864 Thiadiazoles AS CXC- and CC- chemokine receptor ligands
10/05/2006	US20060223836 New phenylalanine derivatives
10/05/2006	US20060223745 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof
10/05/2006	CA2603589A1 Inhibitors of histone deacetylase
10/04/2006	EP1706392A2 Pesticidal heterocyclic dihaloallyl compounds
10/04/2006	EP0906091B1 Amidinohydrazones as protease inhibitors
10/04/2006	CN1277824C Piperazine derivatives
10/04/2006	CN1277823C Novel benzothiazine and benzothiadiazine compounds, its preparation process and pharmaceutical composition containing said compounds
10/03/2006	US7115652 Aspartyl protease inhibitors
10/03/2006	US7115639 useful in the treatment and/or prevention of preterm labor, premature birth and dysmenorrhea; in particular, the present invention is related to pyrrolidine derivatives displaying a substantial modulatory, notably an antagonist activity of the oxytocin receptor
10/03/2006	US7115347 Electroconductive substrate overcoated with photoconductive element
09/2006
09/28/2006	WO2006101105A1 Agent for treatment of psoriasis
09/28/2006	WO2006101104A1 Agent for treatment of arthritis
09/28/2006	WO2006101103A1 Agent for treatment of hematopoietic tumor
09/28/2006	WO2006101102A1 Agent for treatment of solid tumor
09/28/2006	WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
09/28/2006	CA2602559A1 Agent for treatment of hematopoietic tumor
09/28/2006	CA2602397A1 Therapeutic agent for solid tumor
09/27/2006	EP1705482A2 Method of detection, separation and identification for expressed trace protein/peptide
09/27/2006	EP1704143A1 Malononitrile compound as pesticides
09/27/2006	CN1839204A Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
09/21/2006	WO2006098308A1 Novel anthranilic acid derivative or salt thereof
09/21/2006	WO2006098128A1 4-cyclopropyl-1,2,3-thiadiazole compound, agrohorticultural plant disease controlling agent and method of using the same
09/21/2006	WO2006097449A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations
09/21/2006	US20060211697 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents
09/21/2006	US20060211675 Preventives/remedies for urinary disturbance
09/21/2006	US20060211590 Organic catalyst with enhanced solubility
09/21/2006	CA2602609A1 Novel anthranilic acid derivative or salt thereof
09/21/2006	CA2600521A1 N-hydroxyamides omega-substituted with tricyclic groups as histone deacetylase inhibitors, their preparation and use in pharmaceutical formulations

1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 100